InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Lawson Byron, Directeur Commercial. Director active across 1 companies, notably HTG Molecular Diagnostics, INC. Aggregated, 13 filings have been recorded. The latest transaction was filed on 30 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
€2323 shares@ €0.9830.2% of flow
Common Stock
SEC:0001209191-22-040341:0·
€4481,000 shares@ €0.44824.9% of flow
Common Stock
SEC:0001209191-22-036956:0·
€2923 shares@ €1.25540.3% of flow
Common Stock
SEC:0001209191-22-022392:0·
€11524 shares@ €4.78592.7% of flow
Common Stock
SEC:0001209191-22-000857·
€11524 shares@ €4.78591.3% of flow
Common Stock
SEC:0001209191-22-000857:0·
€2,826896 shares@ €3.153665.5% of flow
Common Stock
SEC:0001209191-21-069780·
€2,826896 shares@ €3.153630.9% of flow
Common Stock
SEC:0001209191-21-069780:0·
€11824 shares@ €4.93332.7% of flow
Common Stock
SEC:0001209191-21-058992·
€11824 shares@ €4.93331.3% of flow
Common Stock
SEC:0001209191-21-058992:0·
€11824 shares@ €4.90022.7% of flow
Common Stock
SEC:0001209191-21-045190·
€11824 shares@ €4.90021.3% of flow
Common Stock
SEC:0001209191-21-045190:0·
€1,140354 shares@ €3.219126.4% of flow
Common Stock
SEC:0001209191-21-040446·
€1,140354 shares@ €3.219112.5% of flow
Common Stock
SEC:0001209191-21-040446:0·
13 of 13 declarations
About Lawson Byron
Byron Lawson is Senior Vice President and Chief Commercial Officer at HTG Molecular Diagnostics, Inc. He oversees commercial operations, playing a key role in growth strategy and business development.
